Radionuclide imaging in patients with fever Otto Lang MD Dept Nucl Med 3rd School of Medicine...

Radionuclide imaging in patients with fever

Otto Lang MDDept Nucl Med

3rd School of MedicineCharles University

Prague

materials for medical students

Fever

• Non-specific reaction of the body (T>38oC)

• Most frequent cause inflammation (tumors)

• Inflammation – Infective and non-infective

• Usually fever with other signs of imflammation

• Clinical picture very important

• Other laboratory tests including imaging methods (NM, sono, CT, MRI) are essential

Fever • Probable etiology should be taken into account

– Fever in patient post surgery

– Fever in patient with renal failure

– Fever in patient with HIV positivity

– Fever in patient with septicaemia

– Fever of unknown origin• Fever for 3 weeks with unknown origin despite 1 week intensive hospital

evaluation

– Fever in children

– Fever in soft tissue inflammation

– Fever in bone infection

– Fever in patient with abdominal sepsis

– Fever in patient with different tumors

Fever • Radiopharmaceuticals

– organ specific – show damage of appropriate organ (defect of functioning tissue)

• Tc-99m diphosphonates – bone scan

• Tc-99m DMSA - kidneys

– organ non-specific – accumulates directly in inflammed tissue (little bit tumors, wounds, hematomas)

• Ga-67 citrate – infective, non-infective, tumors

• labeled leukocytes – pyogenic infection

• Tc-99m IgG – non-infective

• F-18 FDG

Ga-67 - properties• Used in a form of citrate• Binds to plasmatic proteins, excretion by

kidneys (24 h) and then intestinal mucosa• Degree of accumulation correlates with

process activity• Basic principles of accumulation:

– Complexes with plasma transferrin– Binds to intracellular lactoferrin inside leukocytes– Can binds directly to some parts of bacteria

• Patient preparation:– Laxatives - fast elimination from the bowel

Ga-67 - procedure

• Injection of 150-180 MBq – high energy, long half-life, high absorbed

dose, worse spatial resolution (image qual)

• Acquisition 4-6 h p.i., then from 24 h to 3-4 days

• Collimator for medium energy

• Whole-body study, spot view (larger frame matrix), SPECT

Ga-67 – clinical significance

• High sensitivity (90%) but low specificity –

used as a locating agent – it locates site of damage so other more specific methods can be used

• More suitable for chronic inflammation

• Not very good for abdominal inflammation evaluation due to physiological excretion via intestinal mucosa

Ga-67 – clinical indications

• Specific inflammation (sarcoidosis, tuberculosis)

• Imunocompromised patients (lung inf)

• Thoracic inflammation (fibrosis, vasculitis)

• Non-infective inflam – process activity (kollagenosis)

• Fever of unknown origin– wide spectrum of possible causes

• Osteomyelitis

• Abdominal and retroperitoneal inflamation (pyelonefritis, absces)

Labeled leucocytesproperties

• Basic pinciples of accumulation– positive chemotaxis (no injury during

labeling process)– also healing wounds and tumors

• Labeling process– in vitro - separation, laboured– in vivo - monoclonal antibodies

• Patient preparation– fasted (blood processing)

Labeled leucocytes procedure

• Labeling – 60 ml venous blood (kids min. 12 ml) – separation, washing up, labeling – cca 1.5 h– Labeling with Tc-99m HMPAO (300 – 500 MBq)

or In-111 oxin (20-40 MBq)

• Data acquisition – 30 min, 4-6, 24 (48 In) h post injection– Whole-body study, spot view (larger frame

matrix), SPECT

Labeled leucocytes clinical indication

• Unspecific bowel disease (Crohn, UC)

• Diabetic foot syndroma

• Musculosceletal infection

• Fever of unknown origin (within 2-3 w)

• Imunocompromised patients

• Joint prosthesis infection

• Acute arthritis

• Vascular prosthesis infection

Tc-99m IgG

• Non-specific polyclonal

• Labeled with In-111 or Tc-99m.

• Accumulates predominantly within interstitial space

• Physiological accumulation – blood-pool, liver, spleen, kindeys, bone marrow and nasal mucosa

• Main indication

– Revmatic (non-infective) inflamation

F-18 FDG• Metabolic analog of glucose

– enter cells but no metabolism – accumulates according to degree of metabolic turnover

• Imaging by PET

• Metabolically active processes (inflam, tumors) - more glucose than other tissue

• Mainly used as a locating agent (like Ga-67) and mark of activity

• PET – much better spatial resolution (better image quality)

New ways

• Imaging of bacteria– labeled chemotherapeuticals (chinolony)

• dependent on antibiotics therapy

• Chemotactic peptides– interleukin 2 – non-infective inflammation

(autoimmune)

• Combined methods– Streptavidin (tissue senzibilization) and then

labeled biotin

Ga-67 citrate

physiological distribution

male and female

Ga-67 - sarkoidosis

Ga-67 – sarkoidosispanda-sign

Ga-67 – sarkoidosispanda and delta sign

Ga-67 – lung fibrosis

Ga-67 - tuberculosis

Ga-67 - urosepticaemia

Ga-67 – thyroiditiscomparison with Tc-99m pertechnetate

Labeled leucocytes

physiological distribution

Labeled leucocytes ulcerative colitis

Labeled leucocytes ulcerative colitis or Crohn´s disease?

Labeled leucocytes ulcerative colitis

Labeled leucocytes infection of hip prosthesis

Diabetic foot syndroma

Patient JU 1961, X-ray chron. OM

Patient JU 1961, bone scan posit.

Patient JU 1961, leu scan negative

F-18 FDGphysiological distribution

FUO

Fever of unknown origin(all methods failed)PET revealed:- aortitis/vasculitisAs a bonus:- Breast cancer(vasculitis as a paraneoplastic sign)

Vascular prosthesis infection PET FDG

Joint prosthesis infectionPET FDG